Cargando…

Expanding the drug discovery space with predicted metabolite–target interactions

Metabolites produced in the human gut are known modulators of host immunity. However, large-scale identification of metabolite–host receptor interactions remains a daunting challenge. Here, we employed computational approaches to identify 983 potential metabolite–target interactions using the Inflam...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nuzzo, Andrea, Saha, Somdutta, Berg, Ellen, Jayawickreme, Channa, Tocker, Joel, Brown, James R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7935942/ https://www.ncbi.nlm.nih.gov/pubmed/33674782 http://dx.doi.org/10.1038/s42003-021-01822-x

Ejemplares similares

Expanding and understanding metabolite space
por: Peironcely, Julio E, et al.
Publicado: (2010)

Expanding roles for academic entrepreneurship in drug discovery
por: Kinch, Michael S., et al.
Publicado: (2020)

Expanding medicinal chemistry into 3D space: metallofragments as 3D scaffolds for fragment-based drug discovery
por: Morrison, Christine N., et al.
Publicado: (2019)

Indole microbial metabolites: expanding and translating target(s)
por: Mani, Sridhar
Publicado: (2017)

Computational Discovery of Putative Leads for Drug Repositioning through Drug-Target Interaction Prediction
por: Coelho, Edgar D., et al.
Publicado: (2016)

Prediction of the P. falciparum Target Space Relevant to Malaria Drug Discovery
por: Spitzmüller, Andreas, et al.
Publicado: (2013)

Modelling human protein interaction networks as metric spaces has potential in disease research and drug target discovery
por: Fadhal, Emad, et al.
Publicado: (2014)

Correction: Expanding medicinal chemistry into 3D space: metallofragments as 3D scaffolds for fragment-based drug discovery
por: Morrison, Christine N., et al.
Publicado: (2022)

Linking biosynthetic and chemical space to accelerate microbial secondary metabolite discovery
por: Soldatou, Sylvia, et al.
Publicado: (2019)

An expanding role for cell biologists in drug discovery and pharmacology
por: Sorger, Peter K., et al.
Publicado: (2012)

Moving targets in drug discovery
por: Zdrazil, Barbara, et al.
Publicado: (2020)

Chemogenomic Approaches for Revealing Drug Target Interactions in Drug Discovery
por: Bhargava, Harshita, et al.
Publicado: (2021)

Further correction: Expanding medicinal chemistry into 3D space: metallofragments as 3D scaffolds for fragment-based drug discovery
por: Morrison, Christine N., et al.
Publicado: (2023)

DiscoverySpace: an interactive data analysis application
por: Robertson, Neil, et al.
Publicado: (2007)

Expanding horizons in complement drug discovery: challenges and emerging strategies
por: Harris, Claire L.
Publicado: (2017)

Microbiota and their metabolites potentiate cancer immunotherapy: Therapeutic target or resource for small molecule drug discovery?
por: Du, Peixin, et al.
Publicado: (2022)

Old drug repositioning and new drug discovery through similarity learning from drug-target joint feature spaces
por: Zheng, Yi, et al.
Publicado: (2019)

Systemic evolutionary chemical space exploration for drug discovery
por: Lu, Chong, et al.
Publicado: (2022)

Small molecule metabolites: discovery of biomarkers and therapeutic targets
por: Qiu, Shi, et al.
Publicado: (2023)

Bivariate One Strain Many Compounds Designs Expand the Secondary Metabolite Production Space in Corallococcus coralloides
por: Lindig, Anton, et al.
Publicado: (2023)

The Discovery of New Drug-Target Interactions for Breast Cancer Treatment
por: Song, Jiali, et al.
Publicado: (2021)

Drug discovery by targeting the protein–protein interactions involved in autophagy
por: Xiang, Honggang, et al.
Publicado: (2023)

Drug Discovery Targeting Post-Translational Modifications in Response to DNA Damages Induced by Space Radiation
por: Xie, Dafei, et al.
Publicado: (2023)

Microbial metabolite mimicry: one step closer to drug discovery
por: Mani, Sridhar
Publicado: (2020)

Predicting the Reliability of Drug-target Interaction Predictions with Maximum Coverage of Target Space
por: Peón, Antonio, et al.
Publicado: (2017)

Tachyons in an Expanding Space-Time
por: Tomaschitz, R
Publicado: (1998)

The enemy within: Targeting host–parasite interaction for antileishmanial drug discovery
por: Lamotte, Suzanne, et al.
Publicado: (2017)

Targeting protein-protein interaction interfaces in COVID-19 drug discovery
por: Chang, Chung-ke, et al.
Publicado: (2021)

Expanding the Chemical Space of Benzimidazole Dicationic Ionic Liquids
por: Mezzetta, Andrea, et al.
Publicado: (2021)

Drug–Target Kinetics in Drug Discovery
por: Tonge, Peter J.
Publicado: (2017)

Understanding and Classifying Metabolite Space and Metabolite-Likeness
por: Peironcely, Julio E., et al.
Publicado: (2011)

Combining Metabolite-Based Pharmacophores with Bayesian Machine Learning Models for Mycobacterium tuberculosis Drug Discovery
por: Ekins, Sean, et al.
Publicado: (2015)

Astrocytes as targets for drug discovery
por: Gorshkov, Kirill, et al.
Publicado: (2018)

Protein-Targeting Drug Discovery
por: Vicidomini, Caterina, et al.
Publicado: (2023)

Physiochemical property space distribution among human metabolites, drugs and toxins
por: Khanna, Varun, et al.
Publicado: (2009)

Expanded transition spaces: the case of Garrwa
por: Gardner, Rod, et al.
Publicado: (2015)

Familiarity expands space and contracts time
por: Jafarpour, Anna, et al.
Publicado: (2016)

Expanding the biomass derived chemical space
por: Brun, Nicolas, et al.
Publicado: (2017)

Approaches to expand the conventional toolbox for discovery and selection of antibodies with drug-like physicochemical properties
por: Svilenov, Hristo L., et al.
Publicado: (2023)

Systematic discovery of drug interaction mechanisms
por: Chevereau, Guillaume, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_m9458rjlia6qupbfaunp0ecpcu